AML-399 Real-World Outcomes of Decitabine + Venetoclax With IDH Inhibition for AML

Clinical Lymphoma, Myeloma and Leukemia - Tập 23 - Trang S297 - 2023
Justin Kusiel1, Praneeth Baratam1,2, Kimberly Green1,2, Alexander Coltoff1,2
1Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
2Department of Hematology and Oncology, Medical University of South Carolina, Charleston, SC, USA

Thông tin
Thông tin xuất bản

Clinical Lymphoma, Myeloma and Leukemia

Tập 23

S297

Thông tin tác giả